Quantis Biotechnology

📍 São Paulo, Brazil🗓 Founded 2020👥 13 employees💰 Last funded Feb 2022
Quantis Biotechnology innovates by using biofabrication and bioprinting to produce high performance human biomaterials and proteins for cell culture, tissue engineering, regenerative medicine and cosmetic industries. We produce a biocompatible, xeno-free and animal-free collagen extracellular matrix that can be used for 2D cell culture assays and also for 3D in vitro models as a scaffold.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in Quantis Biotechnology?
Quantis Biotechnology has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Quantis Biotechnology last raise funding?
The most recent investment in Quantis Biotechnology recorded on gritt.io was in February 2022.
When was Quantis Biotechnology founded?
Quantis Biotechnology was founded in 2020.
What industry is Quantis Biotechnology in?
Quantis Biotechnology operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Quantis Biotechnology based?
Quantis Biotechnology is headquartered in São Paulo, Brazil.